FDA Response to Adverse Event Issues - Sponsored Whitepaper

FDA Response to Adverse Event Issues
Sponsored by:
BioClinica, Inc. Logo
BioClinica, Inc.
Download Entire Whitepaper
In the wake of the recent spate of drug withdrawals and other drug safety issues, there have been renewed calls to reform and enhance the U.S. approach to monitoring safety issues in marketed products. These calls have come from many quarters, and a variety of initiatives have been the result.
Download Entire Whitepaper
Copyright © 2015, Questex Media Group LLC
Company descriptions and contact information are quoted from the company's website or other promotional information. Questex is not responsible for the accuracy of this information. Unless specifically noted, Questex is not sponsored by, affiliated with or otherwise connected with any of the listed companies.